From a biochemical pharmacy lens, Relafen 750 ( Naproxium ) represents a significant case study. Its action of inhibiting cyclooxygenase enzymes, particularly isoenzyme 2 , highlights the subtleties of pain control. The medication's medicinal effect stems from alleviating prostaglandin synthesis , subsequently lessening inflammation and accompanyin